COVID-19 -- Worldwide/Unknown
Three issues are crucial in planning COVID-19 vaccine trials: (1) whether to demand not only proof of some vaccine efficacy but also proof of worthwhile efficacy; (2) whether the initial trials of vaccine against placebo should prioritise not only single-vaccine trials but also a multivaccine trial; and (3) whether to assess safety, protection against severe disease, and duration of protection by continuing blinded follow-up of the vaccine and placebo groups after definite evidence of
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?7733788&promed&0
No comments:
Post a Comment